Hawley Hunts Down the Secrets behind America’s Shady Abortion Drug Maker
It’s the most lethal company no one’s ever heard of — and also, Senator Josh Hawley (R-Mo.) warns, the most secretive. If you asked most Americans what Danco Laboratories is or what it manufactures, only a handful of people would be able to identify it as one of the biggest producers of the abortion pill mifepristone. In fact, it’s the only drug that the company makes. And the reason you don’t know anything about it is because the leftist population control activists who started the business want it that way.
A handful of years ago, The Los Angeles Times dug a little deeper into Danco, publishing a piece in 2023 that ticked off a list of suspicious things about the operation, including the fact that “[i]t has fewer than 20 employees, uses a P.O. Box to avoid sharing its headquarters address and isn’t listed on any public exchanges.” And yet, it’s the mastermind behind the largest industry of death in America today.
“The company’s leadership decided long ago that they would keep its management and structure private due to security and harassment concerns,” Fiona Rutherford reported. “Danco doesn’t share information about its location to be ‘mindful of the safety, privacy and security of the people who work for the company, as well as anybody else who happens to be in the same building,’” the company’s director of Marketing and Public Affairs claimed in an interview with the Times.
But “operating in obscurity isn’t straightforward,” Rutherford explained, pointing out how closely Danco worked with the FDA to keep its details hush-hush. “When it came to the 2000 approval of mifepristone, the agency took additional steps to protect the people involved. All of the documents related to the approval have been redacted so government employee names and manufacturer locations don’t become available to the public.” Even now, Danco refuses to disclose the name of its chief executive, board members, or investors.
And the backstory of the drug now responsible for as many as 70% of U.S. abortions is just as troubling, the Times reveals. “Controversy has followed the abortion pill since it was developed in the 1980s by the French pharmaceutical company Roussel Uclaf. It would take years for the drug to be available to Americans,” Rutherford noted. “After pressure from advocacy groups and the Clinton administration, the reproductive-health nonprofit Population Council secured the rights in 1994 to market the drug in the U.S. The Population Council then looked for a company to sell the pill, a search that ended when Danco was formed to distribute the medication.”
But the cloak-and-dagger tactics raised more than a few eyebrows. “The FDA approval meeting was held in an obscure place in Maryland that looked like a garage, surrounded by security. ‘That tells you everything you need to know right there about what the hurdles were,’” former Planned Parenthood President Gloria Feldt admitted at the time.
That lack of transparency set off alarm bells that are still ringing today in the middle of the most explosive debate over abortion to hit the country in a generation — the widespread use of Danco’s extremely dangerous drug. Senator Hawley, who’s been leading the effort to rein in mifepristone after thousands of reports of widespread harm to women, is also trying to get the Trump administration’s attention about the shady business dealings that are driving an even shadier drug ring.
In a letter to Acting Attorney General Todd Blanch, the Missouri senator urges the Justice Department to open an investigation into Danco’s company policies, practices, approval process, and compliance with federal law. “Very little information is publicly available about Danco Laboratories,” Hawley emphasized. “The company first introduced mifepristone in the United States in 2000 and, in doing so, appears to have taken unusual and extreme measures to protect itself from liability. It was incorporated in the Cayman Islands,” he notes. “Its board of directors and investors remain secret. And its corporate structure remains largely shielded from public view.”
Hawley adds that the origins of the business aren’t exactly nonpartisan. “Early backers appear to have included George Soros and other far-left activists who favor population control. We do know, however, that chemical abortion is a lucrative enterprise for Danco — so lucrative, in fact, that mifepristone is the only drug the company makes, with investors’ returns reportedly topping 450%.” And yet, he notes, Danco is “profiting at the expense of women who have taken the drug and been seriously harmed by it.”
“The largest study of mifepristone ever conducted found that nearly 11% of women who take the drug experience a ‘serious adverse health event,’ such as sepsis or hemorrhaging. That rate amounts to 22 times higher than what Danco admits to on its label,” the senator stresses. “I recently hosted an event which featured firsthand testimonies of women who were harmed by the drug. These women deserve justice for what they suffered at the hands of this shady Big Pharma company.” He concludes by pressuring the DOJ to probe deeply into Danco, pointing out that his Senate subcommittee is doing the same.
An agency spokesperson replied but made no promises that the department would explore Hawley’s request. “President Trump’s record on protecting unborn life and defending women’s health is unmatched. The Department of Justice will continue to advance those priorities by asking courts to allow the FDA to complete its review of mifepristone safety data and by investigating any person or entity that engaged in illegal conduct putting women or unborn children at risk.”
While a Louisiana judge put the brakes on a lawsuit over the abortion drug being mailed between states earlier this month, it didn’t stop the FDA from studying mifepristone’s effects — a process that most conservatives, including Hawley, aren’t convinced the administration has even started. To the senator’s surprise, in a meeting with FDA leaders in February, the intense grassroots and congressional pressure still hasn’t translated into urgency on Commissioner Marty Makary’s behalf.
“I have asked repeatedly in public letters written to the FDA, ‘Have you started the study? When are you starting the study? When will it be done?’ he told Family Research Council President Tony Perkins at the time. “I’ve gotten zero answers from them. Zilch. Zero. There’s been public reporting in the news that the FDA has not even started the study yet. … I don’t know that this is even underway.”
And in the meantime, these drugs are flying off shelves, across state lines, and into pro-life areas with devastating effects. “When you’re talking about the drug mifepristone,” Hawley said to Perkins on last week’s show, “[it] induces an abortion just by ingesting this particular pill, [which] is accountable for 70% now of abortions in the United States. The Biden administration removed all of the safety protocols around this drug,” he reminded people. “We now know it is just inherently unsafe. It is inherently prone to abuse. And my view is we need to just ban it. Congress needs to ban this drug for use in abortion. It is a drug that causes the mother to go to the emergency room with life-threatening conditions in over 10% of cases — more than one in 10.” He paused before adding, “And, of course, it’s lethal to the child almost every time.” At the bare minimum, he implored, the Trump administration needs to restore the “safety guardrails.”
But frankly, Hawley will tell you, America is in a legitimate crisis. “There are more abortions now in the United States than there were when Roe was still the law of the land. And if you live in a pro-life state, it doesn’t matter what your state law is. This abortion drug is being mailed into your state.” It was all part of Joe Biden’s plan to protect abortion-on-demand. “He wanted to make sure that no matter what the Supreme Court said, no matter what voters say, no matter what the state legislatures do, or Congress [does], abortion on demand would remain in America. And his tool for doing that was the abortion drug getting mailed into every city, every town, every state in the Union. We have got to put a stop to that.”
And if pulling back the curtain on the dodgy manufacturer of a drug that’s hospitalizing thousands of women will help people see the evil behind this culture of death, so be it.
Danco is an offshore company “incorporated in the Cayman Islands. Why?” the senator asked rhetorically. “So that they could avoid scrutiny under our legal system. So they could avoid liability or our regulations. Their board of directors is secret. Their investors are secret. Their company protocol, profits, and organization [are] all secret. This is outrageous. … And they make profits to the tune of billions of dollars a year. I want to know who’s funding it. I want to know who’s on their board. I want to know what laws they’re not complying with. We need a full-scale investigation of this abortion drug maker. This Big Pharma company is killing children. It is endangering the lives of women, and they’re getting rich off of it. That should not happen in the United States of America.”
Suzanne Bowdey serves as editorial director and senior writer at The Washington Stand.


